Postmenopausal Osteoporosis Market Share

  • Report ID: 5653
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Postmenopausal Osteoporosis Market Share

APAC Market Statistics

Postmenopausal osteoporosis market in the Asia Pacific region, amongst the market in all the other regions, is slated to hold the largest with a share of about 38% by the end of 2037. The region's growing aging population and accompanying demographic shift are likely to drive market demand. The World Health Organization (WHO) projects that by 2050, the share of older adults in Asia will rise to 28.3%.

Postmenopausal osteoporosis is more common than ever before because of the sharp rise in osteoporosis risk that comes with aging. This demographic trend emphasizes the growing incidence of osteoporosis in the senior population, underscoring the need for targeted healthcare measures.

Osteoporosis is becoming more common in the Asia Pacific region as a result of significant dietary and lifestyle changes. Rising urbanization and changing dietary preferences have resulted in a noticeable decline in traditional diets rich in calcium and other minerals that support bone health. Simultaneously, sedentary lifestyles have grown in favor of postmenopausal osteoporosis market.

North America Market Analysis

The postmenopausal osteoporosis market in North America is expected to develop significantly in the upcoming years and is expected to keep the second position. This is due to the region's population's food and lifestyle choices, which have a significant impact on bone health. Adults in North America are showing a worrying trend of insufficient calcium intake, according to a study published in Osteoporosis International.

Unhealthy food choices, such as consuming less dairy and foods high in calcium, can lead to less than ideal bone health. In order to improve bone density and avoid postmenopausal osteoporosis in the North American population, it is imperative that certain lifestyle variables be addressed.

Research Nester
Postmenopausal Osteoporosis Market size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5653
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of postmenopausal osteoporosis is estimated at USD 10.76 billion.

The postmenopausal osteoporosis market size was over USD 10.31 billion in 2024 and is anticipated to cross USD 20.43 billion by 2037, witnessing more than 5.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is impelled by increasing acceptance of these innovative therapies among healthcare professionals and patients alike.

Asia Pacific industry is predicted to account for largest revenue share of 38% by 2037, due to rising substantial investments in port development in the region.

The major players in the market include Amgen Inc., Eli Lilly and Company, Novartis AG, Pfizer Inc., Merck & Co., Inc., Cipla Inc., Innovent Biologics, Inc., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Private Limited
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample